A commentary by Lynne Cox et al. on ageing, geroprotectors and COVID published in the Lancet Healthy Longevity:
Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults – The Lancet Healthy Longevity, Volume 1, ISSUE 2, e55-e57, November 01, 2020
Three exciting job opportunities for two postdocs and one advanced research assistant to work on screening for genes involved in neurodegenerative disease using iPSC-derived cell types (neurons, astrocytes and microglia). This will use cutting edge CRISPR screening with a single cell RNAseq readout coupled with phenotypic assays to identify and characterise known and putative Alzheimer’s disease, Parkinson’s disease and ALS genes. Read more
A new gift of £1 million will support and advance the study of Longevity Science at Oxford and establish the Mellon Longevity Science Programme at Oriel to help the most vulnerable in society by advancing research into health resilience in ageing populations. Read more